Reuters Health News

Reuters News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 1 hour 39 min ago

Many U.S. kids with brain injuries not getting needed rehab

April 20, 2018 - 2:16pm
(Reuters Health) - Many children hospitalized in the U.S. for brain injuries don't receive all the rehabilitation services needed for them to potentially make a full recovery, a new study suggests.
Categories: Consumer Health News

U.S. biotech companies Alnylam, Dicerna settle trade secrets case

April 20, 2018 - 12:55pm
BOSTON (Reuters) - Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.
Categories: Consumer Health News

Biogen boosts investment in neurology with $1 billion Ionis deal

April 20, 2018 - 10:40am
(Reuters) - Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals on Friday, expanding a partnership that developed the company's potential blockbuster drug for spinal muscular atrophy.
Categories: Consumer Health News

Concussion raises Parkinson's disease risk in large U.S. study

April 20, 2018 - 9:42am
A new study of hundreds of thousands of U.S. armed forces veterans concludes that banging your head severely enough to lose consciousness can dramatically increase the risk of Parkinson's, the brain disease marked by tremors, slow movements, balance problems and difficulty walking.
Categories: Consumer Health News

Losing a spouse late in life linked to cognitive decline

April 20, 2018 - 9:42am
(Reuters Health) - Older adults who lose a spouse may be more vulnerable to cognitive decline in subsequent years and require extra support and monitoring, researchers say.
Categories: Consumer Health News

Germany's Merck seeks partners for cancer and immune system drugs

April 20, 2018 - 8:14am
FRANKFURT (Reuters) - Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.
Categories: Consumer Health News

U.S. appeals court blocks Indiana 'selective' abortion law

April 19, 2018 - 7:37pm
(Reuters) - A federal appeals court on Thursday declared unconstitutional an Indiana law signed by then-Governor Mike Pence that banned women from having abortions because of the gender, race or disability, including Down's syndrome, of their fetuses.
Categories: Consumer Health News

Improving overall heart health may reduce risk of atrial fibrillation

April 19, 2018 - 2:14pm
(Reuters Health) - Following practices recommended for "optimal" heart health may also reduce the risk of developing a serious heart-rhythm disorder, researchers say.
Categories: Consumer Health News

GW Pharma gets FDA panel nod, first cannabis-based drug nearing approval

April 19, 2018 - 1:26pm
(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma.
Categories: Consumer Health News

WHO recommends testing before use of Sanofi's dengue vaccine

April 19, 2018 - 12:22pm
PARIS/CHICAGO (Reuters) - The World Health Organization (WHO) said on Thursday Sanofi's vaccine against dengue should only be used after testing on individuals to assess whether they have ever been exposed to the infection.
Categories: Consumer Health News

Large spleen helps explain deep-diving skills of Southeast Asian 'sea nomads'

April 19, 2018 - 11:34am
(Reuters Health) - An age-old nomadic community of Southeast Asian boat-dwellers who get their food from the sea appear to have evolved enlarged spleens that may help explain their extreme diving prowess, a new study suggests.
Categories: Consumer Health News

FDA staff raises safety concerns over Lilly/Incyte arthritis drug

April 19, 2018 - 9:45am
(Reuters) - An experimental rheumatoid arthritis drug developed by Eli Lilly and Co and Incyte Corp poses serious risks of deadly blood clots at higher doses, U.S. Food and Drug Administration staff said on Thursday, the latest setback to a treatment regulators declined to approve last year.
Categories: Consumer Health News

FDA staff cites safety issues for Lilly, Incyte's rheumatoid arthritis drug

April 19, 2018 - 7:16am
(Reuters) - The U.S. Food and Drug Administration staff on Thursday flagged concerns about potentially fatal blood clots from higher doses of Eli Lilly and Co and Incyte Corp's rheumatoid arthritis drug.
Categories: Consumer Health News

Novartis CEO feels heat on U.S. generics, Cosentyx drop

April 19, 2018 - 7:06am
ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit.
Categories: Consumer Health News

AstraZeneca wins U.S. approval for 1st-line use of lung cancer drug

April 18, 2018 - 7:56pm
(Reuters) - U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the company said on Wednesday.
Categories: Consumer Health News

AstraZeneca wins U.S. FDA approval for first-line use of lung cancer drug

April 18, 2018 - 7:02pm
(Reuters) - AstraZeneca Plc said on Wednesday the U.S. Food and Drug Administration (FDA) has approved the 1st-line use of its lung cancer drug, Tagrisso.
Categories: Consumer Health News

Gates backs gene technologies in fight to end malaria

April 18, 2018 - 6:43pm
LONDON, April 18 (Reuters) - Gene-editing technologies that alter mosquitoes' DNA could prove critical in the fight against malaria, Bill Gates said on Wednesday, and ethical concerns should not block progress in such gene-modifying research.
Categories: Consumer Health News

AI pharma firm BenevolentAI raises $115 million in funding

April 18, 2018 - 6:03pm
LONDON (Reuters) - BenevolentAI, a British pharmaceutical company that uses artificial intelligence to identify new drug candidates, said it had raised $115 million in a funding round that valued it at $2 billion. 
Categories: Consumer Health News

Experts query case for GlaxoSmithKline's new 3-in-1 lung drug

April 18, 2018 - 4:03pm
LONDON (Reuters) - Two medical experts have urged caution in using a new three-in-one inhaler for chronic lung disease from GlaxoSmithKline, which the company hopes will help it keep its lead in respiratory medicine despite rising competition.
Categories: Consumer Health News

Later middle school start times tied to longer sleep for kids

April 18, 2018 - 2:50pm
(Reuters Health) - Starting middle school classes after 8 a.m. could help pre-teens get more sleep and be more awake during their morning lessons, a U.S. study suggests.
Categories: Consumer Health News